Latest Global Markets News

Sunrise Energy Metals has completed a feasibility study for its Syerston Scandium Project, revealing a low-cost, long-life operation poised to supply critical scandium amid tightening Chinese export controls. The project targets production by mid-2028 with strong government backing and a growing global market.

Life360 has delivered a landmark 2025 with record user growth, revenue, and profitability, driven by its expanding subscription base and new advertising ventures. The company’s transition to an AI-first platform and strategic acquisitions set the stage for ambitious growth in 2026.

MFF Capital Investments reported a strong half-year net profit of $209.7 million and declared a fully franked interim dividend of 10 cents per share, signaling confidence despite global economic headwinds. The company’s portfolio remains liquid and focused on high-quality holdings as it navigates geopolitical and technological challenges.

Electro Optic Systems has locked in a $100 million secured loan facility to fuel growth and support its acquisition of MARSS, positioning the company for expansion in counter-drone technologies.

Platformo Ltd reported a modest 5% revenue increase in 2025 driven by its Malaysian subsidiary Biztrak, but faced a higher net loss due to regulatory delays and increased corporate advisory costs.

Uscom Limited has completed the sale of all its international subsidiaries, recording a significant gain but ceasing trading activities and remaining suspended on the ASX. The company now aims to secure a new business to resume operations.

HighCom Limited has revealed a sharp downturn in its half-year results, with revenue plunging 59% and a $6.8 million loss after tax, driven by US government shutdown impacts. The company is banking on new lightweight XTclave® armour products to fuel a recovery in the second half of FY26.

Atlas Pearls reports a challenging first half of FY26 with a 27% drop in revenue and a net loss of $5.2 million, driven by weaker market demand and a shift towards lower-grade pearl sales.

Cynata Therapeutics reported a reduced half-year loss alongside progress in pivotal clinical trials, extending its cash runway into mid-2026. Investors await critical data from Phase 3 and Phase 2 studies expected in the coming months.

Qoria Limited reported a 25% revenue increase to nearly $69 million for H1 FY2026 but also a widening net loss of $24.5 million. The company announced a transformative merger with US-based Aura to create a global digital safety leader.

Orthocell Limited has reported a record half-year revenue of $6.2 million, driven by accelerating sales of its regenerative medicine products and expanding global footprint. The company’s US commercial launch of Remplir™ is gaining momentum alongside new market entries in Canada, Hong Kong, and Europe.

Lark Distilling Co. has reported a solid 10% increase in net sales revenue for the first half of FY26, driven by strong whisky sales and international expansion. The company is gearing up for a major global portfolio launch in the second half, backed by a refreshed brand and enhanced production capacity.